Locoregional Treatment and Palbociclib in de Novo, Treatment Naive, Stage IV ER+, HER2- Breast Cancer Patients
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer Stage IV|Radiotherapy|Surgery
Interventions: DRUG: Palbociclib|OTHER: locoregional treatment
Sponsor: UNICANCER
Collaborators: Pfizer